Quote:
Originally Posted by BayouCountry
|
We use the monoclonal abx treatment for SARSCOV2 + patients that meet criteria, but not as prophylaxis at this point. Of course that could change moving forward. Our medical director follows data closely and adjusts protocols accordingly.
Of course, things change often as we learn more and although some “lay” people get frustrated with information changing, as we gather knowledge, it is good to make recommendations based on what we learn. Guess that’s why they call it “practicing” medicine. Lol.